Cargando…
Development of cannabis use disorder in medical cannabis users: A 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership
BACKGROUND: Evidence for long-term effectiveness of commercial cannabis products used to treat medical symptoms is inconsistent, despite increasingly widespread use. OBJECTIVE: To prospectively evaluate the effects of using cannabis on self-reported symptoms of pain, insomnia, anxiety, depression, a...
Autores principales: | Cooke, Megan E., Potter, Kevin W., Jashinski, Julia, Pascale, Michael, Schuster, Randi M., Tervo-Clemmens, Brenden, Hoeppner, Bettina B., Pachas, Gladys N., Evins, A. Eden, Gilman, Jodi M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027723/ https://www.ncbi.nlm.nih.gov/pubmed/36960460 http://dx.doi.org/10.3389/fpsyt.2023.1083334 |
Ejemplares similares
-
Assessing Changes in Symptoms of Depression and Anxiety During Four Weeks of Cannabis Abstinence Among Adolescents
por: Cooke, Megan E., et al.
Publicado: (2021) -
Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial
por: Gilman, Jodi M., et al.
Publicado: (2022) -
Variation in Cannabinoid Metabolites Present in the Urine of Adults Using Medical Cannabis Products in Massachusetts
por: Gilman, Jodi M., et al.
Publicado: (2021) -
Using Functional Near-Infrared Spectroscopy to Measure Effects of Delta 9-Tetrahydrocannabinol on Prefrontal Activity and Working Memory in Cannabis Users
por: Keles, Hasan O., et al.
Publicado: (2017) -
Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocol
por: Jashinski, Julia, et al.
Publicado: (2022)